CANCER BIOMARK 润色咨询

Cancer Biomarkers

出版年份:2005 年文章数:1193 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:2.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:预后指标;肝癌预后<br>经验分享:2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条(纯临床研究,虽然问题多,但都比较好回答,没有让我补充数据)<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:属实非常慢的杂志了,8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:强烈劝退,审稿9个月,review意见回来应该是1个拒稿2个大修,1个月后编辑拒稿,理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向:肿瘤标志物<br>经验分享:投了将近一个月,现在状态是under review是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊,现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:从提交到一审意见回来经历了4个多月,四个审稿人,两个小修两个大修,结果编辑给的意见是拒稿,说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向: 肿瘤 <br>经验分享:3月26后投稿,6月15日小修,6月26日修回,7月18号接收,感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2023-05-29 ms3000000907122076 来自广西

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:预后指标;肝癌预后
    经验分享:2023.3.18 submission---under review
    2023.4.21 major revise 8条 minor revise 3条(纯临床研究,虽然问题多,但都比较好回答,没有让我补充数据)
    2023.5.08 resubmission---under review
    2023.5.23 under review---process in decision
    2023.5.28 accept

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:预后指标;肝癌预后<br>经验分享:2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条(纯临床研究,虽然问题多,但都比较好回答,没有让我补充数据)<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:属实非常慢的杂志了,8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:强烈劝退,审稿9个月,review意见回来应该是1个拒稿2个大修,1个月后编辑拒稿,理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向:肿瘤标志物<br>经验分享:投了将近一个月,现在状态是under review是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊,现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:从提交到一审意见回来经历了4个多月,四个审稿人,两个小修两个大修,结果编辑给的意见是拒稿,说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向: 肿瘤 <br>经验分享:3月26后投稿,6月15日小修,6月26日修回,7月18号接收,感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2023-04-05 jiarong 来自湖南省

    审稿速度:12.0 | 投稿命中率:75.0
    偏重的研究方向:肿瘤
    经验分享:属实非常慢的杂志了,8个月到1年起吧

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:预后指标;肝癌预后<br>经验分享:2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条(纯临床研究,虽然问题多,但都比较好回答,没有让我补充数据)<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:属实非常慢的杂志了,8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:强烈劝退,审稿9个月,review意见回来应该是1个拒稿2个大修,1个月后编辑拒稿,理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向:肿瘤标志物<br>经验分享:投了将近一个月,现在状态是under review是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊,现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:从提交到一审意见回来经历了4个多月,四个审稿人,两个小修两个大修,结果编辑给的意见是拒稿,说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向: 肿瘤 <br>经验分享:3月26后投稿,6月15日小修,6月26日修回,7月18号接收,感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2022-08-24 YC1025

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享:强烈劝退,审稿9个月,review意见回来应该是1个拒稿2个大修,1个月后编辑拒稿,理由非常不专业

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:预后指标;肝癌预后<br>经验分享:2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条(纯临床研究,虽然问题多,但都比较好回答,没有让我补充数据)<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:属实非常慢的杂志了,8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:强烈劝退,审稿9个月,review意见回来应该是1个拒稿2个大修,1个月后编辑拒稿,理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向:肿瘤标志物<br>经验分享:投了将近一个月,现在状态是under review是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊,现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:从提交到一审意见回来经历了4个多月,四个审稿人,两个小修两个大修,结果编辑给的意见是拒稿,说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向: 肿瘤 <br>经验分享:3月26后投稿,6月15日小修,6月26日修回,7月18号接收,感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2022-06-20 ms8000001241612634

    偏重的研究方向:肿瘤标志物
    经验分享:投了将近一个月,现在状态是under review是什么意思?

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:预后指标;肝癌预后<br>经验分享:2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条(纯临床研究,虽然问题多,但都比较好回答,没有让我补充数据)<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:属实非常慢的杂志了,8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:强烈劝退,审稿9个月,review意见回来应该是1个拒稿2个大修,1个月后编辑拒稿,理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向:肿瘤标志物<br>经验分享:投了将近一个月,现在状态是under review是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊,现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:从提交到一审意见回来经历了4个多月,四个审稿人,两个小修两个大修,结果编辑给的意见是拒稿,说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向: 肿瘤 <br>经验分享:3月26后投稿,6月15日小修,6月26日修回,7月18号接收,感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2020-02-04 Liuying11

    我的一天就给了稿号闪电下课 2019-08-04 发表::
    投稿后一般多久会给稿号啊,现在想看看状态都看不了
    闪电下课 2019-08-04 16:38:00 发表:
    投稿后一般多久会给稿号啊,现在想看看状态都看不了

    闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊,现在想看看状态都看不了

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:预后指标;肝癌预后<br>经验分享:2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条(纯临床研究,虽然问题多,但都比较好回答,没有让我补充数据)<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:属实非常慢的杂志了,8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:强烈劝退,审稿9个月,review意见回来应该是1个拒稿2个大修,1个月后编辑拒稿,理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向:肿瘤标志物<br>经验分享:投了将近一个月,现在状态是under review是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊,现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:从提交到一审意见回来经历了4个多月,四个审稿人,两个小修两个大修,结果编辑给的意见是拒稿,说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向: 肿瘤 <br>经验分享:3月26后投稿,6月15日小修,6月26日修回,7月18号接收,感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-12-28 学医的彭于晏

    什么时候需要highlights部分?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:预后指标;肝癌预后<br>经验分享:2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条(纯临床研究,虽然问题多,但都比较好回答,没有让我补充数据)<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:属实非常慢的杂志了,8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:强烈劝退,审稿9个月,review意见回来应该是1个拒稿2个大修,1个月后编辑拒稿,理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向:肿瘤标志物<br>经验分享:投了将近一个月,现在状态是under review是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊,现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:从提交到一审意见回来经历了4个多月,四个审稿人,两个小修两个大修,结果编辑给的意见是拒稿,说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向: 肿瘤 <br>经验分享:3月26后投稿,6月15日小修,6月26日修回,7月18号接收,感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-12-28 乌云背后的幸福线

    highlights部分的一般要求是什么?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:预后指标;肝癌预后<br>经验分享:2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条(纯临床研究,虽然问题多,但都比较好回答,没有让我补充数据)<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:属实非常慢的杂志了,8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:强烈劝退,审稿9个月,review意见回来应该是1个拒稿2个大修,1个月后编辑拒稿,理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向:肿瘤标志物<br>经验分享:投了将近一个月,现在状态是under review是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊,现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:从提交到一审意见回来经历了4个多月,四个审稿人,两个小修两个大修,结果编辑给的意见是拒稿,说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向: 肿瘤 <br>经验分享:3月26后投稿,6月15日小修,6月26日修回,7月18号接收,感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-07-24 ms6000001325372637

    审稿速度:6.0
    偏重的研究方向:肿瘤
    经验分享:从提交到一审意见回来经历了4个多月,四个审稿人,两个小修两个大修,结果编辑给的意见是拒稿,说我按照意见修改好之后欢迎我再重投。。。

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:预后指标;肝癌预后<br>经验分享:2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条(纯临床研究,虽然问题多,但都比较好回答,没有让我补充数据)<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:属实非常慢的杂志了,8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:强烈劝退,审稿9个月,review意见回来应该是1个拒稿2个大修,1个月后编辑拒稿,理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向:肿瘤标志物<br>经验分享:投了将近一个月,现在状态是under review是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊,现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:从提交到一审意见回来经历了4个多月,四个审稿人,两个小修两个大修,结果编辑给的意见是拒稿,说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向: 肿瘤 <br>经验分享:3月26后投稿,6月15日小修,6月26日修回,7月18号接收,感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-05-28 ms1000000930252947

    请问单基因的生信无验证可以投吗

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:预后指标;肝癌预后<br>经验分享:2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条(纯临床研究,虽然问题多,但都比较好回答,没有让我补充数据)<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:属实非常慢的杂志了,8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:强烈劝退,审稿9个月,review意见回来应该是1个拒稿2个大修,1个月后编辑拒稿,理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向:肿瘤标志物<br>经验分享:投了将近一个月,现在状态是under review是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊,现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊,现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:从提交到一审意见回来经历了4个多月,四个审稿人,两个小修两个大修,结果编辑给的意见是拒稿,说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向: 肿瘤 <br>经验分享:3月26后投稿,6月15日小修,6月26日修回,7月18号接收,感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-07-19 147fa11bm80暂无昵称

    偏重的研究方向: 肿瘤
    经验分享:3月26后投稿,6月15日小修,6月26日修回,7月18号接收,感觉还挺好的

    0

共103条页码: 1/11页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分